Dekkun Corporation

PharmaceuticalsSeries BCambridge, US

Latest round

Series B

Last raised

Jan 2011

Total raised

$7M

Investors

1

About Dekkun Corporation

Dekkun Corporation develops pharmaceutical technologies. It offers humanized antibodies for the treatment of bone fractures and oncology.

Who invested in Dekkun Corporation

1 investor across 1 round

See all investors in Dekkun Corporation

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Jan 3, 2011

    Amount

    $7M

    Investors

    Locked

Questions about Dekkun Corporation

Who invested in Dekkun Corporation?

Dekkun Corporation has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Dekkun Corporation raised?

Dekkun Corporation has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Dekkun Corporation last raise money?

Dekkun Corporation's most recent round on record is a Series B, in Jan 2011.

What does Dekkun Corporation do?

Dekkun Corporation develops pharmaceutical technologies.

Where is Dekkun Corporation headquartered?

Dekkun Corporation is headquartered in Cambridge, US.

Which VCs invest in companies like Dekkun Corporation?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Dekkun Corporation's stage. Their profiles are linked below.

Raising like Dekkun Corporation? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.